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Abstract
Background: The population in Norway has become multi-ethnic due to migration from Asia and Africa over the
recent decades. The aim of the present study was to explore differences in the self-reported prevalence of
cardiovascular disease (CVD) and associated risk factors by diabetes status in five ethnic minority groups compared
to ethnic Norwegians.
Methods: Pooled data from three population-based cross-sectional studies conducted in Oslo between 2000 and
2002 was used. Of 54,473 invited individuals 24,749 (45.4%) participated. The participants self-reported health status,
underwent a clinical examination and blood samples were drawn. A total of 17,854 individuals aged 30 to 61 years
born in Norway, Sri-Lanka, Pakistan, Iran, Vietnam or Turkey were included in the study. Chi-square tests, one-way
ANOVAs, ANCOVAs, multiple and logistic regression were used.
Results: Age- and gender-standardized prevalence of self-reported CVD varied between 5.8% and 8.2% for the
ethnic minority groups, compared to 2.9% among ethnic Norwegians (p < 0.001). Prevalence of self-reported
diabetes varied from 3.0% to 15.0% for the ethnic minority groups versus 1.8% for ethnic Norwegians (p < 0.001).
Among individuals without diabetes, the CVD prevalence was 6.0% versus 2.6% for ethnic minorities and
Norwegians, respectively (p < 0.001). Corresponding CVD prevalence rates among individuals with diabetes were
15.3% vs. 12.6% (p = 0.364). For individuals without diabetes, the odds ratio (OR) for CVD in the ethnic minority
groups remained significantly higher (range 1.5-2.6) than ethnic Norwegians (p < 0.05), after adjustment for age,
gender, education, employment, and body height, except for Turkish individuals. Regardless of diabetes status,
obesity and physical inactivity were prevalent in the majority of ethnic minority groups, whereas systolic- and
diastolic- blood pressures were higher in Norwegians. In nearly all ethnic groups, individuals with diabetes had
higher triglycerides, waist-to-hip ratio (WHR), and body mass index compared to individuals without diabetes. Age,
diabetes, hypertension, hypercholesterolemia, and WHR were significant predictors of CVD in both ethnic
Norwegians and ethnic minorities, but significant ethnic differences were found for age, diabetes, and
hypercholesterolemia.
Conclusions: Ethnic differences in the prevalence of CVD were prominent for individuals without diabetes. Primary
CVD prevention including identification of undiagnosed diabetes should be prioritized for ethnic minorities without
known diabetes.
Keywords: Cardiovascular disease, diabetes, ethnicity, socioeconomic position, risk factors.
* Correspondence: a.t.tran@medisin.uio.no
1Department of General Practice, Institute of Health and Society, University
of Oslo, Oslo, Norway
Full list of author information is available at the end of the article
Tran et al. BMC Public Health 2011, 11:554
http://www.biomedcentral.com/1471-2458/11/554
© 2011 Tran et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Background
Over 80% of the global burden of cardiovascular disease
(CVD) occurs in low- and middle-income countries, and
large variations in risk factor profiles and disease rates
by ethnic groups have been reported [1,2]. Migration
from low- to high-income countries may lead to
changes in CVD risk factors [3], and most, but not all,
ethnic minority groups (EMGs) demonstrate a higher
prevalence of risk factors for CVD [4-6] and a higher
incidence of CVD than the general population [7,8].
Diabetes is well established as an important risk factor
for CVD and type 2 diabetes increases the risk of coron-
ary heart disease (CHD) by two to four folds in popula-
tions of European descent [9]. Immigrants from Asia
and Africa living in Europe have a higher prevalence of
diabetes than Europeans [10-12]. In the UK, CHD mor-
tality rates among South Asians are 1.5 times that of the
general population [13], while the ethnic difference in
CVD mortality are three times higher among individuals
with diabetes [14]. Social disadvantage is associated with
CVD and most of the associated risk factors [15] and
ethnic disparities in socioeconomic position (SEP) con-
tribute to the observed ethnic inequalities in health out-
comes, including CVD and diabetes [15,16].
Due to migration from Asia and Africa over recent
decades, the capital of Norway (Oslo) has now become
multi-ethnic, with approximately 27% of the population
comprised by first and second generation ethnic minori-
ties [17]. Previous studies of five EMGs in Oslo have
revealed significant group differences in levels of serum
triglycerides (TG), high-density lipoprotein (HDL)-cho-
lesterol, blood pressure (BP), and smoking prevalence
[18,19]. Furthermore, EMGs from Asia had a high pre-
valence of diabetes and CHD [19-21], and socioeco-
nomic position differed between and within the various
EMGs [20]. It remains unknown whether the high CVD
prevalence rate among ethnic minorities in Norway is
attributable to the high prevalence of diabetes.
The aim of the present study was to assess the preva-
lence of self-reported CVD and its associated risk fac-
tors stratified by diabetes status, and to investigate the
associations between risk factors and CVD in five EMGs
compared to ethnic Norwegians.
Methods
Participants and setting
Between 2000 and 2002, three population-based, cross-
sectional studies were conducted in Oslo by The Nor-
wegian Institute of Public Health, in collaboration with
the University of Oslo, the Norwegian University of
Sport and Physical Education, the Oslo Diabetes
Research Centre and the Oslo Municipality. These three
studies included the Oslo Health Study, the Oslo
Immigrant Health Study, and the Romsås in Motion
Study. These studies will be collectively referred to as
the Oslo Health Studies in the present study. Although
different population subgroups were targeted, the same
protocol was used for all three studies (for additional
details, see [18,19,21-24]).
In the Oslo Health Study, a total of 18,770 (46%) of all
Oslo residents born in 1924, 1925, 1940, 1941, 1955,
1960 and 1970 participated [22]. In the Oslo Immigrant
Health Study, a total of 7,607 residents born in Sri-
Lanka, Pakistan, Iran, Vietnam and Turkey between the
years 1942 and 1971 were invited and 39.7% (N = 3,019)
participated [23]. In the Romsås in Motion Study, a total
of 2,960 (48%) of all residents born between 1933 and
1969 in two districts with low SEP and a multi-ethnic
population participated [24]. The Oslo Health Studies
were approved by the Regional Ethics Committee
South-Eastern A and The Norwegian Data Inspectorate.
In the present study, data from the Oslo Health Stu-
dies were pooled, such that the total number of invited
participants was 54,473, of which 45.4% (N = 24,749)
participated. We restricted our analyses to participants
aged 30 to 61 years old who were born in Norway, Sri-
Lanka, Pakistan, Iran, Vietnam, and Turkey between
1940 and 1971 (N = 18,523). Of these, 13,273 (71.7%)
were from the Oslo Health Study, 3,019 (16.3%) from
the Oslo Immigrant Health Study, and 2,231 (12.0%)
from the Romsås in Motion Study. A total of 669 (3.6%)
participants were excluded either due to missing data
for diabetes status, which was a stratification variable (N
= 563), or participation in more than one study (specifi-
cally, N = 106 individuals from the Romsås in Motion
Study), leaving a final sample of 17,854 participants.
The questionnaires were translated into five languages
(Tamil, Urdu, Persian, Vietnamese and Turkish) and
included information on self-reported diabetes, angina
pectoris (AP), myocardial infarction (MI), stroke, use of
medication, health-related behaviours, education, and
employment status (full- or part-time). Body height
(cm), weight (kg), and waist and hip circumference (cm)
were measured and body mass index (BMI; kg/m2) and
waist-to-hip ratio (WHR) were calculated.
Variables
Ethnicity was assigned by country of birth data supplied
by Statistics Norway. The majority of the participants
from Asia and the Middle East (aged 30 to 61 years)
were first-generation immigrants when the Oslo Health
Studies were conducted. Cardiovascular disease was
defined as the self-reported occurrence of AP, MI, or
stroke. Hypertension was defined as one of the follow-
ing: systolic blood pressure (SBP) ≥ 140 mmHg, diastolic
blood pressure (DBP) ≥ 90 mmHg, use of
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antihypertensive medications, and hypercholesterolemia
defined by a total cholesterol ≥ 6.2 mmol/l, or the use
of lipid-lowering medications [19]. To assess SEP, we
used self-reported years of education to define early
adulthood SEP and employment status (full- or part-
time; yes vs. no) as a proxy for adult SEP. Body height
was used as a proxy for early-life SEP [21,25,26]. Level
of physical activity was categorized as sedentary if parti-
cipants reported reading and watching TV as their main
leisure-time activities.
Statistical analyses
Due to dissimilar age distributions among the ethnic
groups, the prevalence of CVD and diabetes with 95%
confidence intervals (CIs) were standardized by age and
gender using direct standardization methods with ethnic
Norwegians in the study sample as the reference stan-
dard. Differences in prevalence rates between the
groups, and between the particular ethnic minority
group and the ethnic Norwegians were tested by likeli-
hood ratio tests and z-tests respectively.
Chi-squared tests and one-way ANOVAs were applied
to investigate differences in proportions and means,
respectively, between the ethnic groups. Adjusted means
and mean differences were estimated and tested by ana-
lyses of covariance (ANCOVAs). Due to a highly skewed
distribution, the triglyceride values were log-transformed
before applying the ANCOVA and the results were
back-transformed to the original scale using anti-log.
The minority groups were pooled in some of the
logistic regression analyses due to small numbers of
individuals with CVD and diabetes. Adjusted odds ratios
(OR; 95% CI) of having CVD by diabetes status in the
minority groups compared to ethnic Norwegians were
estimated by multiple logistic regression analyses.
Associations between self-reported CVD and asso-
ciated risk factors were examined by logistic regression
analyses. Two-way interactions between country of birth
and CVD risk factors were tested by likelihood ratio
tests. Two-sided tests were used and p-values ≤0.05
were considered statistically significant. The analyses
were performed with SPSS 18.0 and STATA 11.0. The
graphs were made in R 2.11.1 for Windows.
Results
Of the 17,854 participants aged 30 to 61 years old, 8,371
(46.9%) were men, 13,967 (78.2%) were born in Norway,
and 3,887 (21.9%) were born in Sri Lanka, Pakistan,
Iran, Vietnam or Turkey. The groups differed by age,
education and employment (Table 1).
Diabetes was reported by a total of 562 (3.1%) and
CVD by 603 (3.4%) participants, of which 471 (2.6%)
reported one CVD diagnosis (AP: 219, MI: 116, stroke:
136), 117 (0.7%) reported two diagnoses (AP and MI:
100, AP and stroke: 15, MI and stroke: 2), and 15
(0.08%) reported three CVD diagnoses. For ethnic Nor-
wegians, 48 (12.5%) of those reporting CVD also
reported diabetes, compared to 50 (22.8%) among the
ethnic minorities after pooling all groups. The age- and
gender-standardized prevalence rate of self-reported
CVD was significantly higher for all EMGs (Sri Lanka:
5.8%, Pakistan: 7.4%, Iran: 7.5%, Vietnam: 8.2%, Turkey:
6.8%) than ethnic Norwegians (2.9%, p < 0.001 for
between groups difference) (Figure 1). The EMGs also
reported significantly more diabetes (age- and gender-
standardized; Sri-Lanka: 13.4%, Pakistan: 15.0%, Iran:
Table 1 Baseline characteristics for participants (N = 17,854) by country of birth
Characteristicsa Norway
(n = 13967)
Sri Lanka
(n = 1127)
Pakistan
(n = 859)
Iran
(n = 695)
Vietnam
(n = 658)
Turkey
(n = 548)
pb
Men
% (95% CI)
44.5 (43.6-45.3) 60.0 (57.1-62.8) 54.2 (50.9-57.6) 59.8 (56.2-63.4) 45.8 (42.0-49.6) 55.3 (51.1-59.4) < 0.001
Age, years
Mean (95% CI)
45.2 (45.0-45.4) 39.6 (39.2-39.9) 43.3 (42.7-43.9) 41.6 (41.1-42.1) 43.2 (42.6-43.8) 41.5 (40.9-42.2) < 0.001
Self-reported CVD
Valid cases (n)
Age at diagnosis, years
Mean (95% CI)
384
46.6 (45.6-47.7)
44
46.2 (42.5-49.8)
59
48.2 (45.2-51.1)
41
44.3 (41.0-47.6)
43
43.8 (40.6-47.1)
32
47.1 (43.0-51.2) 0.335
Self-reported DM
Valid cases (n)
Age at diagnosis, years
Mean (95% CI)
260
40.4 (38.8-42.0)
99
44.2 (41.6-46.8)
115
41.4 (39.1-43.8)
17
39.8 (33.0-46.5)
38
45.9 (41.3-50.4)
33
44.1 (40.0-48.3) 0.057
Education, years
Mean (95% CI)
14.1 (14.0-14.2) 12.8 (12.5-13.0) 10.1 (9.8-10.4) 14.1 (13.8-14.5) 10.8 (10.5-11.2) 8.5 (8.0-9.0) < 0.001
Employment
% (95% CI)
86.4 (85.8-87.0) 77.6 (75.1-80.0) 54.0 (50.5-57.5) 66.1 (62.5-69.6) 69.0 (65.3-72.6) 57.5 (53.2-61.7) < 0.001
aCVD: cardiovascular disease (i.e., angina pectoris or myocardial infarction or stroke). DM: diabetes mellitus. Employment included full-time or part-time work.
b p-values. Chi-square tests and one-way ANOVAs were applied for testing differences in proportions and in means between groups, respectively. Multiple
regression models were applied to compare mean age at diagnososis of CVD and diabetes between groups adjusted for age.
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3.0%, Vietnam: 6.7%, Turkey: 9.1% vs. Norwegians: 1.8%,
p < 0.001).
Individuals with diabetes reported more CVD than
those without diabetes, irrespective of ethnicity (Figure
2A). The ratio between CVD prevalence for individuals
with and without diabetes was 4.8 for ethnic Norwegians
and 2.6 for the pooled EMG. Among individuals without
diabetes, the CVD prevalence was higher for the pooled
EMG compared with Norwegians (6.0% vs. 2.6%, p <
0.001) (Figure 2B). Among individuals with diabetes, the
CVD prevalence for the pooled EMG was not signifi-
cantly higher than ethnic Norwegians (15.3% vs.12.6%,
n.s.).
For individuals without diabetes, OR for CVD adjusted
for age and gender (Model 1) was higher for all EMGs
(ranging from 2.1 for Sri-Lankans to 3.5 for Iranians),
compared with Norwegians (p < 0.001, Table 2). After
additional adjustment for adult SEP as determined by
education and employment status (Model 2), and body
height as a measure of early-life SEP (Model 3), the eth-
nic differences in OR for CVD were reduced, yet ORs in
the EMGs still remained higher than ethnic Norwegians
(1.5-2.6, p < 0.05), except for participants from Turkey.
For individuals with diabetes, however, OR for CVD did
not significantly differ between the pooled EMG and
Norwegian group.
For the majority of cardiovascular risk factors, ethnic
differences were observed regardless of diabetes status
(Table 3). Compared to ethnic Norwegians, most EMGs
had higher levels of TG, total cholesterol/HDL-choles-
terol ratio, WHR, BMI, and they reported less physical
activity. On the other hand, most of the EMGs had
lower SBP and DBP than Norwegians. In the Norwegian
and Pakistani groups, individuals with diabetes had
higher SBP than those without diabetes. In nearly all
ethnic groups, individuals with diabetes had higher TG,
WHR, and BMI compared to individuals without dia-
betes. When applying the definition of obesity proposed
by the WHO for Asians (BMI ≥ 25 kg/m) to partici-
pants without diabetes, 58.4% of Sri-Lankans, 76.3% of
Pakistanis and 28.1% of Vietnamese were obese (values
adjusted for age and gender), compared to obesity rates
of 65.9%, 92.0%, and 55.8% for individuals with diabetes
for these groups, respectively. Daily smoking was most
prevalent among ethnic Norwegians and men from
Turkey.
Figure 1 Prevalence (% with 95% CI) of self-reported
cardiovascular disease (CVD) by ethnicity. Bars: CVD prevalence,
|: 95% CI, p-value: ethnic difference in CVD prevalence between the
particular ethnic group and the Norwegian reference group (ref).
Figure 2 Prevalence (% with 95% CI) of cardiovascular disease
(CVD) by diabetes status and ethnicity. Nor: Norwegians; Emg:
the pooled ethnic minority group. Bars: CVD prevalence, |: 95% CI,
p-value: difference in CVD prevalence between those with and
without diabetes in Norwegians and the pooled ethnic minority
group (A) and between Norwegians and the pooled ethnic minority
group by diabetes status (B).
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Table 2 Odds ratios for cardiovascular disease in individuals with and without diabetes by country of birth
Variablea Country
of birth
Valid
Cases
Model 1b Model 2c Model 3d
OR (95% CI) Pe OR (95% CI) Pe OR (95% CI) Pe
CVD,
Diabetes, no
Norway 336 Ref Ref Ref
Sri Lanka 31 2.1 (1.4-3.0) < 0.001 1.8 (1.2-2.7) 0.003 1.7 (1.1-2.6) 0.017
Pakistan 37 2.6 (1.8-3.7) < 0.001 1.6 (1.1-2.4) 0.019 1.5 (1.0-2.3) 0.048
Iran 39 3.5 (2.4-4.9) < 0.001 2.8 (1.9-4.0) < 0.001 2.6 (1.7-3.9) < 0.001
Vietnam 33 3.0 (2.0-4.4) < 0.001 2.3 (1.6-3.5) < 0.001 2.1 (1.4-3.4) 0.001
Turkey 29 3.3 (2.2-5.0) < 0.001 1.6 (1.0-2.6) 0.061 1.5 (0.9-2.5) 0.112
CVD
Diabetes, yes
Norway 48 Ref Ref Ref
Other countries 50 1.3 (0.8-2.0) 0.378 1.2 (0.7-2.1) 0.471 1.2 (0.6-2.1) 0.729
a CVD: self-reported cardiovascular disease; Diabetes, no: cases not reporting diabetes; Diabetes, yes: reported diabetes.
b,c,d Logistic regression was used to estimate odds ratios (ORs) for self-reported CVD in the minority groups compared to the reference group (Norwegians).
Adjusted for age and gender in Model 1. Additionally adjusted for education and employment in Model 2. Further adjusted for body height in Model 3.
Table 3 Risk factorsa for cardiovascular disease in individuals with and without diabetes by country of birth
Risk factorb Diabetes
status
Norway
(N = 13967)
Sri Lanka
(N = 1127)
Pakistan
(N = 859)
Iran
(N = 695)
Vietnam
(N = 658)
Turkey
(N = 548)
% CVD/DMc 2.9/1.8 5.8/13.3 7.4/15.0 7.5/3.0 8.2/6.7 6.9/9.1
BMI, kg/m2
Mean (95% CI)
DM,no
DM,yes
25.6 (25.5-25.7)
28.8 (28.3-29.3)
26.0 (25.8-26.3)
26.6 (25.8-27.4)
28.0 (27.7-28.3)
29.9 (29.2-30.7)
26.4 (26.1-26.7)
28.1 (26.1-30.0)
23.5 (23.2-23.8)
25.3 (24.0-26.6)
28.9 (28.6-29.3)
30.8 (29.4-32.2)
p = < 0.001 0.199 < 0.001 0.092 0.010 0.012
WHratio,
Mean (95% CI)
DM,no
DM,yes
0.84 (0.84-0.85)
0.90 (0.89-0.91)
0.88 (0.88-0.89)
0.92 (0.91-0.93)
0.89 (0.89-0.90)
0.93 (0.92-0.95)
0.85 (0.84-0.85)
0.89 (0.86-0.92)
0.84 (0.83-0.84)
0.88 (0.85-0.90)
0.87 (0.86-0.87)
0.90 (0.88-0.92)
p = <0.001 <0.001 <0.001 0.007 0.001 0.004
SBP, mmHg
Mean (95%CI)
DM,no
DM,yes
128.4(128.1-128.7)
132.1(130.2-134.1)
123.7(122.8-124.7)
126.1(123.1-129.2)
124.2(123.1-125.4)
129.7(126.9-132.5)
121.1(119.9-122.2)
124.8(117.5-132.0)
121.5(120.3-122.7)
121.1(116.2-125.9)
123.5(122.1-124.8)
127.2(122.0-132.4)
p = < 0.001 0.136 < 0.001 0.326 0.871 0.172
DBP, mmHg
Mean (95% CI)
DM,no
DM,yes
74.9 (74.7-75.0)
74.7 (73.4-75.9)
74.3 (73.7-75.0)
74.7 (72.7-76.7)
74.5 (73.8-75.2)
75.5 (73.7-77.4)
72.1 (71.3-72.8)
73.6 (68.8-78.4)
72.8 (72.0-73.6)
73.0 (69.7-76.2)
73.2 (72.3-74.1)
73.0 (69.6-76.5)
p = 0.761 0.751 0.307 0.540 0.919 0.925
S-Chol/
HDL-chol ratio
Mean (95% CI)
DM,no
DM,yes
4.0 (4.0-4.1)
4.3 (4.2-4.5)
4.9 (4.8-4.9)
4.8 (4.6-5.1)
4.8 (4.7-4.9)
5.1 (4.8-5.3)
4.5 (4.4-4.6)
4.6 (4.0-5.2)
4.1 (4.0-4.2)
4.3 (3.9-4.8)
4.7 (4.5-4.8)
4.9 (4.5-5.3)
p = < 0.001 0.822 0.051 0.600 0.325 0.274
S-TG,
mean (95% CI)
DM,no
DM,yes
1.6 (1.5-1.6)
2.1 (1.8-2.4)
2.0 (1.6-2.4)
2.8 (1.3-5.8)
2.2 (1.9-2.4)
3.2 (2.5-4.2)
1.7 (1.3-2.2)
2.2 (0.8-6.1)
1.6 (1.4-1.9)
2.1 (1.2-3.8)
2.4 (2.0-2.8)
3.9 (1.9-8.2)
p = < 0.001 0.064 < 0.001 0.948 0.382 0.001
% Current smoker DM,no
DM,yes
30.4 (29.6-31.1)
39.8 (32.4-47.3)
12.1 (9.3-14.9)
11.7 (5.0-18.4)
21.7 (18.5-24.9)
10.6 (4.7-16.4)
34.8 (30.8-39.0)
24.4 (4.4-44.4)
17.9 (14.7-21.0)
17.8 (4.6-30.9)
37.5 (33.0-42.0)
55.6 (35.6-75.6)
p = 0.021 0.916 0.001 0.315 0.988 0.085
% Sedentary DM,no
DM,yes
21.2 (20.4-21.9)
25.0 (18.6-31.4)
54.6 (50.1-59.1)
46.7 (35.4-57.9)
56.7 (52.7-60.7)
59.0 (47.8-70.3)
46.8 (42.3-51.3)
70.1 (46.9-93.3)
57.4 (53.1-61.7)
44.7 (26.9-62.6)
55.1 (50.1-60.2)
74.7 (55.2-94.1)
p = 0.238 0.200 0.704 0.053 0.178 0.056
a Age- and gender- adjusted risk factors. Triglycerides were also adjusted for time since last meal before the blood sample was taken. The prevalence of smoking
and sedentary behaviour were adjusted for age.
b SBP: systolic blood pressure, DBP: diastolic blood pressure, S-Chol/HDL-chol ratio: S-cholesterol/HDL-cholesterol ratio, TG: triglyceride, WHR: waist-to-hip ratio,
BMI: body mass index, Sedentary: reading and watching TV as main leisure-time activities.
The triglyceride variable was log-transformed before applying the multiple regression model for estimation due to highly skewed distribution of the data. The
results (estimates and 95% confidence intervals) were transformed back to the original scale using anti-log.
cCVD/DM: age- and gender-standardized prevalence of self-reported cardiovascular disease or diabetes mellitus.
p-values. Multiple regression models were applied to estimate marginal mean values and examine differences between those with and without diabetes in the
particular ethnic group, adjusted for age, gender, ethnicity and diabetes status.
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The multivariate logistic regression analyses revealed
that age, diabetes, hypertension, hypercholesterolemia,
and WHR were significant risk factors for CVD in both
the Norwegian group and the pooled EMG. Education
was inversely associated with CVD and the OR for CVD
was lower in women than men for ethnic Norwegians,
but these associations were weaker among the pooled
EMG. Ethnic differences were observed in OR for age,
diabetes, and hypercholesterolemia (Table 4). Odds
ratios for CVD when reporting diabetes were lower in
the pooled EMG compared to Norwegians (2.2 vs. 4.4, p
= 0.024).
Discussion
The present study investigated differences in the preva-
lence of cardiovascular disease and associated risk fac-
tors by diabetes status in five ethnic minority groups
living in Norway. Higher rates of cardiovascular disease
were found among all ethnic minority groups compared
to ethnic Norwegians, yet these differences were not
related to diabetes status. Specifically, a higher preva-
lence of CVD in the pooled EMG was found exclusively
among participants without diabetes. For these indivi-
duals, the odds ratio for CVD remained higher in most
of the ethnic minority groups compared to ethnic Nor-
wegians after adjustment for age, gender, and socio-eco-
nomic position.
The high prevalence rates of cardiovascular disease
and diabetes among ethnic minorities are in accordance
with other Norwegian [19,21], and European studies
[8,12,27]. The prevalence of self-reported diabetes
among individuals from Sri-Lanka (13.4%) and Pakistan
(15%) was somewhat lower than for South Asians living
in the UK and US (20% and 18%, respectively) [28].
Several studies indicate that about 40-50% of diabetes
cases may be undiagnosed [21,29]. We were unable to
address undiagnosed diabetes in our study, and this may
have contributed to the higher CVD prevalence in eth-
nic minorities without an established diagnosis of dia-
betes. The small ethnic difference in CVD prevalence
among individuals reporting diabetes may indicate that
a diagnosis of diabetes alerts doctors to treat CVD risk
factors more actively regardless of ethnicity, following
clinical guidelines that recommend regular visits to the
general practitioner (GP). In line with this result, a
study from Oslo found no ethnic differences in process
of care for patients with type 2 diabetes treated in pri-
mary care [30]. As the immigrant population from Asia
and Africa is rather young in Norway, GPs may be una-
ware of the greater susceptibility for CVD than diabetes
among ethnic minorities, as the latter is typically more
prevalent during middle age. In addition, barriers to life-
style intervention may exist for GPs and/or ethnic min-
ority patients. Cultural beliefs, norms, and values in
certain groups (e.g., a large body size is “healthier” than
a thin one, exercise is not associated with health), as
well as limited economic opportunities, may fail to
encourage physical activity [31]. Furthermore, many first
generation ethnic minorities are exposed to a rapid tran-
sition of lifestyle characterized by an increased intake of
energy dense foods and reduced need for daily physical
activity, leading to obesity, dyslipidemia and thus,
increased risk of CVD upon immigration [28]. Other
factors, such as a higher level of psychosocial distress
[32] which is not captured by the traditional risk factor
assessments, may also contribute to the observation that
ethnic minorities without diabetes had a less favourable
risk factor profile and higher prevalence of CVD, despite
Table 4 Odds ratios (OR) for cardiovascular disease (CVD) by risk factors in the ethnic groups
Risk factorsa Norwegian group Ethnic minority groupb
ORc (95% CI) ORc (95% CI) Pd
Age (≥ 50 years vs. < 50 years) 4.4 (3.2-5.9) 2.4 (1.7-3.3) 0.008
Gender (women vs. men) 0.5 (0.4-0.7) 0.8 (0.5-1.2) 0.070
Self-reported diabetes (yes vs. no) 4.4 (2.9-6.6) 2.2 (1.4-3.4) 0.024
WHR (continuous) 1.2 (1.0-1.4) 1.4 (1.1-1.8) 0.276
Current smoking (yes vs. no) 1.2 (0.9-1.5) 1.3 (0.9-1.8) 0.854
Hypertension (yes vs. no) 1.9 (1.5-2.5) 1.9 (1.3-2.6) 0.899
Hypercholesterolemia (yes vs. no) 2.6 (2.0-3.3) 1.7 (1.2-2.3) 0.029
Education duration
10-12 years vs. 0-9 years 0.8 (0.6-1.1) 0.7 (0.5-1.1) 0.773
13-15 years vs. 0-9 years 0.7 (0.5-0.9) 0.9 (0.6-1.4) 0.286
> 15 years vs. 0-9 years 0.5 (0.4-0.7) 0.8 (0.5-1.2) 0.190
a Risk factors for CVD: age, gender, diabetes status, WHR = waist-to-hip ratio, Hypertension = Systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥
90 mmHg or use of medication for hypertension, Hypercholesterolemia = serum cholesterol ≥ 6.2 mmol/l or use of lipid-lowering medications.
b Ethnic minority group: pooled group with individuals born in Sri Lanka, Pakistan, Iran, Vietnam and Turkey.
c Logistic regression was applied to estimate odds ratios (OR) with 95% CI for CVD for risk factors. Each OR was adjusted for all other variables in the table.
d p: significance level of the interaction between the particular risk factor and country of birth adjusted for the other variables.
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lower blood pressure. Similar risk factor profile differ-
ences between ethnic minorities and the general popula-
tion have been reported by others [5,33-35].
The relationships between socioeconomic position,
ethnicity, and health are complex and dynamic, varying
across countries and over time [36]. Nevertheless, there
is growing evidence that a large part of ethnic disparities
in health are a consequence of socioeconomic differ-
ences [37]. The majority of ethnic minority groups in
our study were more disadvantaged than ethnic Norwe-
gians, as indicated by lower levels of education and
employment. In line with these findings, the ethnic dif-
ferences in ORs for CVD among individuals without
diabetes were reduced, yet remained significant follow-
ing adjustment for socioeconomic position, except for
the relatively small Turkish group. However, residual
confounding may exist due to our reliance on rather
crude measures of SEP [37].
The value of clinical measures of generalized or cen-
tral obesity in the assessment of cardiovascular risk in
primary prevention is not entirely clear, as national and
international guidelines have provided different recom-
mendations [38]. Among Norwegians, waist-to-hip ratio
was not strongly associated with CVD and might not
improve CVD risk prediction when additional informa-
tion about diabetes status, hypertension, and hypercho-
lesterolemia are available [39]. In contrast, obesity was
prevalent for all EMGs and waist-to-hip ratio should be
treated as a strong predictor of CHD in these groups
[39,40].
A notable strength of this population-based study is
the sampling technique, which was based upon the
unique personal identity number assigned to all Norwe-
gian residents. This approach arguably improves the
study’s representativeness and further, enabled an
assessment of selection bias, as the population registries
include demographic and socioeconomic data in addi-
tion to country of birth for all residents. From a public
health perspective, studies that investigate and monitor
health disparities along ethnic lines are warranted,
owing to the rapid demographic transition over the past
decades in Norway. To facilitate participation in the
Oslo Health Studies, fieldworkers fluent in participants’
native languages provided assistance. Our study, which
included a large sample of first-generation immigrants
drawn from Norway’s largest ethnic minorities, enabled
a comparison with ethnic Norwegians and extends prior
research regarding health disparities among ethnic
minorities not least in Norway, but also in Scandinavia.
In particular, rather few studies have investigated the
health status of Sri Lankan and Vietnamese populations
in Europe.
Several limitations deserve acknowledgment. Our
study is limited by a cross-sectional design, whereas a
high-quality and prospective registration of cardiovascu-
lar disease would have enabled a more precise investiga-
tion of disease burden. Additionally, there were
relatively low participation rates and small number of
angina, MI, stroke and diabetes cases among some eth-
nic groups. Therefore, CVD included all three diagnoses
to improve the statistical power. Nevertheless, a com-
prehensive analysis of the non-attendance in the Oslo
Health Study concluded that prevalence estimates were
robust despite considerable non-attendance [41]. This
finding also applied to the ethnic minority participants.
Furthermore, the five ethnic minority groups accounted
for 22% of the study population, whereas ethnic minori-
ties (first and second generation) comprised 20% in the
background population in Oslo at the time of the Oslo
Health Studies, providing evidence to support the
study’s representativeness. Although the prevalence esti-
mates may nevertheless be prone to some selection bias,
it is feasible that the associations between risk factors
and outcomes within the ethnic groups would be less
affected.
Self-reported chronic disease may be affected by
recall and misclassification bias, possibly yielding an
underestimate of disease prevalence, particularly
undiagnosed or subclinical disease. Similarly, gender
and ethnic differences in self-reported symptoms have
been observed. For example, women and immigrants
from South Asia living in the UK are more likely to
report atypical angina symptoms than men and Cauca-
sians [42,43]. Nevertheless, two studies have shown
high levels of concordance between self-reported
health (i.e., diabetes, AP, MI and stroke) and medical
records, providing some support to the validity of this
self-reported data [44,45]. Still, it is possible these find-
ings fail to apply to ethnic minorities in Norway due to
inadequate translation procedures, insensitivity of
items, or other reasons [46]. However, one study speci-
fically addressing cross-cultural validity found no evi-
dence for marked ethnic differences in the accuracy of
self-reported diabetes [47].
Due to the small number of CVD and diabetes cases,
combined with the dissimilar gender distribution among
different ethnic groups, we were unable to examine gen-
der differences in the prevalence of CVD or risk factor
profile. Despite the limitations of the study, however, we
feel that any potential selection bias fails to explain find-
ings of ethnic differences in the prevalence of self-
reported diabetes and CVD, especially among indivi-
duals without diabetes.
Our study results have implications for health-care
policy and education. Specifically, health professionals,
as well as ethnic minority communities, should be
aware of significant ethnic differences in the burden of
cardiovascular disease, diabetes, and their associated
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risk profiles. In addition to bolstering existing preven-
tion efforts, such as secondary prevention of CVD and
primary prevention of CVD among diabetes patients, a
need exists for better detection of undiagnosed dia-
betes and primary prevention of CVD among ethnic
minorities. This topic is not given special attention in
the recent guidelines of primary prevention of CVD
[48]. In particular, the finding that women from ethnic
minority groups share a similar risk for CVD as their
male counterparts deserves greater awareness. More-
over, improved primary intervention of CVD using cul-
turally sensitive methods that promote physical activity
and weight reduction in minorities is essential and fea-
sible [49]. Not least, national strategies to reduce eth-
nic disparities in SEP are required and may
subsequently reduce ethnic differences in CVD and
diabetes [37]. Longitudinal studies are needed to moni-
tor ethnic disparities in risk profile and disease rates,
and to assist with the development and evaluation of
targeted preventive strategies [50].
Conclusions
Ethnic differences in the prevalence of cardiovascular
disease were most prominent for individuals without
diabetes. Improved primary prevention of CVD and
more intensive case-finding strategies of undiagnosed
diabetes in ethnic minority groups are needed to reduce
unnecessary ethnic differences in CVD in the future.
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